Title:
PHARMACEUTICAL COMPOSITION FOR TREATING COLORECTAL DISEASE CONTAINING CYSTATIN D
Document Type and Number:
WIPO Patent Application WO/2018/164296
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition for treating colorectal disease, which contains cystatin D. The pharmaceutical composition of the present invention, which contains cystatin D, exhibits a significantly increased inhibitory effect against colorectal cancer compared to when cystatin is not used. Thus, the pharmaceutical composition of the present invention will be effectively used as a therapeutic agent against colorectal cancer in the medical field.
Inventors:
CHUNG MYUNG JUN (KR)
Application Number:
PCT/KR2017/002515
Publication Date:
September 13, 2018
Filing Date:
March 08, 2017
Export Citation:
Assignee:
CELL BIOTECH CO LTD (KR)
International Classes:
A61K38/00; A23L33/18
Foreign References:
US20140038902A1 | 2014-02-06 | |||
US20100041167A1 | 2010-02-18 | |||
US20070117164A1 | 2007-05-24 |
Other References:
ALVAREZ-DIAZ ET AL.: "Cystatin D is a candidate tumor suppressor gene induced by vitamin D in human colon cancer cells", THE JOURNAL OF CLINICAL INVESTIGATION, vol. 119, no. 8, 2009, pages 2343 - 2358, XP055549500
MAGISTER ET AL.: "Cystatins in immune system", JOURNAL OF CANCER, vol. 4, no. 1, 2013, pages 45 - 56, XP055114756
MAGISTER ET AL.: "Cystatins in immune system", JOURNAL OF CANCER, vol. 4, no. 1, 2013, pages 45 - 56, XP055114756
Attorney, Agent or Firm:
HONESTY & JR PARTNERS INTELLECTUAL PROPERTY LAW GROUP (KR)
Download PDF: